The Cell-Based Assays Market is estimated to grow at the rate of 16.6% CAGR by 2026. A cell-based assay is an experiment that uses live cells. The basic methods include different assays that can be used in computing cell toxicity, growth, motility, and the production of a particular cellular product and cellular morphology. Cell-based assays offer the nearest depiction of the real-life model as it employs live cells in experimentation. The factors accelerating the cell-based assays market are the increasing elderly population and the increasing occurrence of chronic diseases, including cancer, diabetes, and epilepsy. Additionally, the significantly increasing drug discovery is anticipated to escalate the demand for cell-based assays since it is majorly used in examining the efficiency of drugs. Several companies are involved in the drug discovery, which requires cell-based assay for reviewing the new drugs, which are expected to boost the cell-based assays market in the prevailing years. Simultaneously, the restraining factors of the market include the high costs of the assays and lack of skilled labor in this field.
Cell-Based Assays Market based on Product & Service
- Consumables
o Reagents
o Assay Kits
o Probes & Labels
o Microplates
o Cell Lines
- Instruments
- Services
Cell-Based Assays Market based on Application
- Drug Discovery
- Basic Research
- Other Applications
Cell-Based Assays Market based on End-User
- Pharmaceutical & Biotechnology Companies
- Academic & Government Institutes
- Contract Research Organizations
Cell-Based Assays Market based on Geography
- North America
- Europe
- Asia Pacific
- Rest of World
The market is based on products & services, and this segment is further segmented into consumables, instruments, and services. The consumables segment is likely to hold the highest share in the market. The highest share is majorly ascribed to the increasing usage and requirement in the pre-requisite steps of cell-based assay methodologies
Based on the application of cell-based assays, the market is categorized into drug discovery, basic research, and other applications. The drug discovery segment is witnessing a significant growth rate in the market due to the increase in investments in research and developments for drug discovery by various biopharmaceutical companies and the development of drugs to treat multiple diseases.
Then further based on end-users, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, and Contract Research Organizations. The pharmaceutical and biotechnology companies segment has acquired a significant share in the market growth. This is due to the increasing demand for new drugs to globally treat various diseases among the rising elderly population. Rising competition among the healthcare companies and increasing research and development activities by pharmaceutical and biotechnology companies are the major factors boosting the segment growth.
In the regional market of cell-based assays, the North American region has occupied the market's substantial share. Factors including the presence of various numbers of pharmaceutical companies, drastically growing drug-based developments and research activities, and a rising number of well-established biotechnological laboratories are accelerating the region's market growth.
Cell-based assays occupy various advantages over conventional biochemical assays and animal models, and these advantages have majorly driven the rising demand for these assays in the present years. There is increasing usage of cell-based assays as the preferred tool for testing potential drug compounds and toxicity testing, increasing demand from the drug development companies. The cell-based assays demand will increase further due to increased allotment of resources to drug discovery by companies, the existence of many proteins of which functions are yet to be known, and the rising demand for biological drugs.
Prominent players of the market are Becton, Dickinson and Company, Charles River Laboratories, Inc., Cell Signaling Technology, Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Lonza Group Ltd., Cell Biolabs, Inc., General Electric Company, Merck KGaA, Perkinelmer, Inc., Promega Corporation, Cisbio Bioassays, and Discoverx Corporation.
The cell-based assays are having a prominent role in the present scenario of a rising number of diseases worldwide in the discovery and development of drugs since these cell-based assays provide enormous benefits in screening all types of compounds.
- This research segments the cell-based assays market entirely and gives the nearest evaluations of the complete market size and the sub-segments among significant regions.
- This report provides insightful analyses of the market and provides a comprehensive understanding of the cell-based assays market and its commercial landscape.
- Provides information about the market strategies which the competitors and leading organizations are adopting.
- This report provides the perception of the future outlook and prospects for cell-based assays market analysis and forecast.
Same as Description
Table of Contents
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Product & Service: Market Size & Analysis
5.1. Overview
5.2. Consumables
5.2.1. Reagents
5.2.2. Assay Kits
5.2.3. Probes & Labels
5.2.4. Microplates
5.2.5. Cell Lines
5.3. Instruments
5.4. Services
6. Application: Market Size & Analysis
6.1. Overview
6.2. Drug Discovery
6.3. Basic Research
6.4. Other Applications
7. End User: Market Size & Analysis
7.1. Overview
7.2. Pharmaceutical & Biotechnology Companies
7.3. Academic & Government Institutes
7.4. Contract Research Organizations
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. Becton, Dickinson and Company
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. Charles River Laboratories, Inc.
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. Cell Signaling Technology, Inc.
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. Danaher Corporation
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. Thermo Fisher Scientific Inc.
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. Lonza Group Ltd.
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. Cell Biolabs, Inc.
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. General Electric Company
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. Merck KGaA
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. Perkinelmer, Inc.
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. Companies to Watch
11.1. Promega Corporation
11.1.1. Overview
11.1.2. Products & Services
11.1.3. Business Strategy
11.2. Cisbio Bioassays
11.2.1. Overview
11.2.2. Products & Services
11.2.3. Business Strategy
11.3. Discoverx Corporation
11.3.1. Overview
11.3.2. Products & Services
11.3.3. Business Strategy
11.3.4.
12. Analyst Opinion
13. Annexure
13.1. Report Scope
13.2. Market Definitions
13.3. Research Methodology
13.3.1. Data Collation and In-house Estimation
13.3.2. Market Triangulation
13.3.3. Forecasting
13.4. Report Assumptions
13.5. Declarations
13.6. Stakeholders
13.7. Abbreviations
Tables
TABLE 1. GLOBAL CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
TABLE 2. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR CONSUMABLES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 3. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR REAGENTS, BY TYPE, 2020-2026 (USD BILLION)
TABLE 4. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR ASSAY KITS, BY TYPE, 2020-2026 (USD BILLION)
TABLE 5. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR PROBES & LABELS, BY TYPE, 2020-2026 (USD BILLION)
TABLE 6. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR MICROPLATES, BY TYPE, 2020-2026 (USD BILLION)
TABLE 7. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR CELL LINES, BY TYPE, 2020-2026 (USD BILLION)
TABLE 8. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR INSTRUMENTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 9. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 10. GLOBAL CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 11. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR DRUG DISCOVERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 12. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR BASIC RESEARCH, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 13. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 14. GLOBAL CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 15. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 16. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR ACADEMIC & GOVERNMENT INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 17. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR CONTRACT RESEARCH ORGANIZATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 18. NORTH AMERICA CELL-BASED ASSAYS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 19. NORTH AMERICA CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
TABLE 20. NORTH AMERICA CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 21. NORTH AMERICA CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 22. U.S CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
TABLE 23. U.S CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 24. U.S CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 25. CANADA CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
TABLE 26. CANADA CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 27. CANADA CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 28. EUROPE CELL-BASED ASSAYS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 29. EUROPE CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
TABLE 30. EUROPE CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 31. EUROPE CELL-BASED ASSAYS MARKET VALUE, END USER, 2020-2026 (USD BILLION)
TABLE 32. GERMANY CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
TABLE 33. GERMANY CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 34. GERMANY CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 35. U.K CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
TABLE 36. U.K CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 37. U.K CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 38. FRANCE CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
TABLE 39. FRANCE CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 40. FRANCE CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 41. ITALY CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
TABLE 42. ITALY CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 43. ITALY CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 44. SPAIN CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
TABLE 45. SPAIN CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 46. SPAIN CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 47. ROE CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
TABLE 48. ROE CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 49. ROE CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 50. ASIA PACIFIC CELL-BASED ASSAYS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 51. ASIA PACIFIC CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
TABLE 52. ASIA PACIFIC CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 53. ASIA PACIFIC CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 54. CHINA CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
TABLE 55. CHINA CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 56. CHINA CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 57. INDIA CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
TABLE 58. INDIA CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 59. INDIA CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 60. JAPAN CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
TABLE 61. JAPAN CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 62. JAPAN CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 63. REST OF APAC CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
TABLE 64. REST OF APAC CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 65. REST OF APAC CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 66. REST OF WORLD CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
TABLE 67. REST OF WORLD CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 68. REST OF WORLD CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 69. BECTON, DICKINSON AND COMPANY: FINANCIALS
TABLE 70. BECTON, DICKINSON AND COMPANY: PRODUCT AND SERVICES
TABLE 71. BECTON, DICKINSON AND COMPANY: RECENT DEVELOPMENTS
TABLE 72. CHARLES RIVER LABORATORIES, INC: FINANCIALS
TABLE 73. CHARLES RIVER LABORATORIES, INC: PRODUCT AND SERVICES
TABLE 74. CHARLES RIVER LABORATORIES, INC: RECENT DEVELOPMENTS
TABLE 75. CELL SIGNALING TECHNOLOGY, INC: FINANCIALS
TABLE 76. CELL SIGNALING TECHNOLOGY, INC: PRODUCT AND SERVICES
TABLE 77. CELL SIGNALING TECHNOLOGY, INC: RECENT DEVELOPMENTS
TABLE 78. DANAHER CORPORATION: FINANCIALS
TABLE 79. DANAHER CORPORATION: PRODUCT AND SERVICES
TABLE 80. DANAHER CORPORATION: RECENT DEVELOPMENTS
TABLE 81. THERMO FISHER SCIENTIFIC INC: FINANCIALS
TABLE 82. THERMO FISHER SCIENTIFIC INC: PRODUCT AND SERVICES
TABLE 83. THERMO FISHER SCIENTIFIC INC: RECENT DEVELOPMENTS
TABLE 84. LONZA GROUP LTD: FINANCIALS
TABLE 85. LONZA GROUP LTD: PRODUCT AND SERVICES
TABLE 86. LONZA GROUP LTD: RECENT DEVELOPMENTS
TABLE 87. CELL BIOLABS, INC: FINANCIALS
TABLE 88. CELL BIOLABS, INC: PRODUCT AND SERVICES
TABLE 89. CELL BIOLABS, INC: RECENT DEVELOPMENTS
TABLE 90. GENERAL ELECTRIC COMPANY: FINANCIALS
TABLE 91. GENERAL ELECTRIC COMPANY: PRODUCT AND SERVICES
TABLE 92. GENERAL ELECTRIC COMPANY: RECENT DEVELOPMENTS
TABLE 93. MERCK KGAA: FINANCIALS
TABLE 94. MERCK KGAA: PRODUCT AND SERVICES
TABLE 95. MERCK KGAA: RECENT DEVELOPMENTS
TABLE 96. PERKINELMER, INC: FINANCIALS
TABLE 97. PERKINELMER, INC: PRODUCT AND SERVICES
TABLE 98. PERKINELMER, INC: RECENT DEVELOPMENTS
TABLE 99. PROMEGA CORPORATION: PRODUCT AND SERVICES
TABLE 100. CISBIO BIOASSAYS: PRODUCT AND SERVICES
TABLE 101. DISCOVERX CORPORATION: PRODUCT AND SERVICES
Charts
CHART. 1. GLOBAL CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
CHART. 2. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR CONSUMABLES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 3. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR REAGENTS, BY TYPE, 2020-2026 (USD BILLION)
CHART. 4. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR ASSAY KITS, BY TYPE, 2020-2026 (USD BILLION)
CHART. 5. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR PROBES & LABELS, BY TYPE, 2020-2026 (USD BILLION)
CHART. 6. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR MICROPLATES, BY TYPE, 2020-2026 (USD BILLION)
CHART. 7. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR CELL LINES, BY TYPE, 2020-2026 (USD BILLION)
CHART. 8. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR INSTRUMENTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 9. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 10. GLOBAL CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 11. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR DRUG DISCOVERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 12. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR BASIC RESEARCH, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 13. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 14. GLOBAL CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 15. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 16. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR ACADEMIC & GOVERNMENT INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 17. GLOBAL CELL-BASED ASSAYS MARKET VALUE FOR CONTRACT RESEARCH ORGANIZATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 18. NORTH AMERICA CELL-BASED ASSAYS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 19. NORTH AMERICA CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
CHART. 20. NORTH AMERICA CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 21. NORTH AMERICA CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 22. U.S CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
CHART. 23. U.S CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 24. U.S CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 25. CANADA CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
CHART. 26. CANADA CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 27. CANADA CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 28. EUROPE CELL-BASED ASSAYS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 29. EUROPE CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
CHART. 30. EUROPE CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 31. EUROPE CELL-BASED ASSAYS MARKET VALUE, END USER, 2020-2026 (USD BILLION)
CHART. 32. GERMANY CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
CHART. 33. GERMANY CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 34. GERMANY CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 35. U.K CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
CHART. 36. U.K CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 37. U.K CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 38. FRANCE CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
CHART. 39. FRANCE CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 40. FRANCE CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 41. ITALY CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
CHART. 42. ITALY CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 43. ITALY CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 44. SPAIN CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
CHART. 45. SPAIN CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 46. SPAIN CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 47. ROE CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
CHART. 48. ROE CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 49. ROE CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 50. ASIA PACIFIC CELL-BASED ASSAYS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 51. ASIA PACIFIC CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
CHART. 52. ASIA PACIFIC CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 53. ASIA PACIFIC CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 54. CHINA CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
CHART. 55. CHINA CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 56. CHINA CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 57. INDIA CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
CHART. 58. INDIA CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 59. INDIA CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 60. JAPAN CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
CHART. 61. JAPAN CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 62. JAPAN CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 63. REST OF APAC CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
CHART. 64. REST OF APAC CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 65. REST OF APAC CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 66. REST OF WORLD CELL-BASED ASSAYS MARKET VALUE, BY PRODUCT & SERVICE, 2020-2026 (USD BILLION)
CHART. 67. REST OF WORLD CELL-BASED ASSAYS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 68. REST OF WORLD CELL-BASED ASSAYS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
Becton
Dickinson and Company
Charles River Laboratories
Inc.
Cell Signaling Technology
Inc.
Danaher Corporation
Thermo Fisher Scientific Inc.
Lonza Group Ltd.
Cell Biolabs
Inc.
General Electric Company
Merck KGaA
Perkinelmer
Inc.
Promega Corporation
Cisbio Bioassays
and Discoverx Corporation.